Dr. Schauder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
719 Thompson Ln
Suite 26300
Nashville, TN 37204Phone+1 615-322-6485Fax+1 615-343-2591
Summary
- David Schauder, MD, PhD, is an Assistant Professor of Dermatology at Vanderbilt University Medical Center. He received his undergraduate degree in biochemistry at University of Michigan. He earned an MD/PhD through the Medical Scientist Training Program at Medical College of Wisconsin, where he was elected to the Alpha Omega Alpha national medical honor society. He completed his internship at University of Colorado and residency in dermatology at Vanderbilt University, where he served as Chief Resident and was awarded the Lloyd E. King, Jr. Excellence in Teaching Award. He has multiple publications in respected dermatology and immunology journals to his credit, including the Journal of the American Academy of Dermatology, JAMA Dermatology, Pediatric Dermatology, Proceedings of the National Academy of Sciences, Frontiers in Immunology, and the Journal of Leukocyte Biology.
Education & Training
- Vanderbilt University Medical CenterResidency, Dermatology, 2021 - 2024
- University of ColoradoInternship, Internal Medicine, 2020 - 2021
- Medical College of WisconsinClass of 2020
- University of Michigan-Ann ArborBS, Biochemistry, 2006 - 2010
Certifications & Licensure
- TN State Medical License 2024 - 2026
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Implementation of an adjustable standing desk inking station for improved ergonomics in Mohs surgeryDavid M. Schauder, Rajiv I. Nijhawan
Journal of the American Academy of Dermatology. 2021-03-01 - Pharmacogenomics of Fluoropyrimidines-a Personalized Approach for Treating and Preventing Keratinocyte Carcinomas-Reply.David M. Schauder, Rajiv I. Nijhawan
JAMA Dermatology. 2021-03-01 - 20 citationsEvaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.David M. Schauder, Jinwan Kim, Rajiv I. Nijhawan
JAMA Dermatology. 2020-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: